DYADIC INTERNATIONAL, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Delaware
THIS INDEMNIFICATION AGREEMENT (this "Agreement") is made as of the __ day of ____, ____, by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the "Company"), and [NAME OF OFFICER OR DIRECTOR] ("Indemnitee").
RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
RESTRICTED STOCK AGREEMENT made this ___________ day of ___________ by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the “Company”), ___________ (“Stockholder”).
INTRACOASTAL POINTE OFFICE BUILDING LEASE AGREEMENTLease Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
THIS LEASE AGREEMENT (sometimes hereinafter referred to as the "Lease") is made and entered into this 30th day of December, 2010 by and between Quentin Partners Co. as Agent for lntracoastal Pointe, Inc., (Florida corporations) (hereinafter collectively called "Landlord"), whose address for purposes hereof is 851 S.E. Johnson Avenue, Suite 100, Stuart, Florida 34994; and Dyadic International, Inc., (hereinafter called "Tenant"). Tenant's address, for purposes hereof until commencement of the term of this Lease, being 140 lntracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 and thereafter being that of the Leased Premises (hereinafter defined).
EMPLOYMENT AGREEMENTEmployment Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
EMPLOYMENT AGREEMENT ("Agreement") made and entered into as of May 1, 2016 by and between DYADIC INTERNATIONAL, INC., a Delaware corporation, with its principal place of business at 140 lntracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 (the "Company"), and THOMAS L. DUBINSKI, a resident of Florida ("Employee"). (The Company and Employee are sometimes hereinafter jointly referred to as the "parties" and individually as a "party.")
indicates that a confidential portion of the text of this agreement has been omitted. The non-publicMutual Nondisclosure Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Bern
EMPLOYMENT AGREEMENTEmployment Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
EMPLOYMENT AGREEMENT ("Agreement") made this 16th day of June, 2016 by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the "Company"), and MARK A. EMALFARB, a resident of the State of Florida (the "Executive").
INVESTMENT AGREEMENT with respect toShareholders Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
Hereinafter the persons and companies identified in items (1) through (9) will be jointly referred to as the “Existing Shareholders”.
LICENSE AGREEMENTLicense Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
WHEREAS, VTT has developed certain technology related to expression systems for micro- organisms and to promoters in expression systems;
CONSULTANT AGREEMENTConsultant Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
THIS CONSULTANT AGREEMENT ("Agreement") is made and entered as of the 1st day of January, 2016 ("Effective Date") by and between DYADIC NEDERLAND B.V. (the "Company"), and Sky Blue Biotech kft. ("Consultant"). As part of the Agreement, Consultant is required to engage Ronen Tchelet, an individual born on July 20, 1957 and currently residing in Budapest, Hungary. Ronen Tchelet shall be personally bound by the same obligations and covenants of Consultant in this agreement. The Company and Consultant are each sometimes individually referred to as a "Party" and collectively, as the "Parties." Capitalized terms used herein shall have the meaning provided in this Agreement including, but not limited to, as set forth in Section 5.8 hereof.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
This RESEARCH SERVICES AGREEMENT (this “Agreement”), signed as of June 30, 2017, is entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation with headquarters located at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094 USA and U.S. tax identification number 45-04867472 (“Dyadic”), and BIOTECHNOLOGY DEVELOPMENTS FOR INDUSTRY IN PHARMACEUTICALS, S.L.U., a company incorporated under the laws of Spain having its registered office at Louist Proust 13, 47151 Boecillo (Valladolid), Spain, and identification code -CIF number- B-86206695 (“BDI Pharmaceuticals”). Dyadic and BDI Pharmaceuticals are sometimes collectively referred to as the “Parties” and individually as a “Party.” Certain capitalized terms used herein have the meanings assigned them in Article 1 hereof.
CONSULTING AGREEMENTConsulting Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
THIS CONSULTING AGREEMENT (“Agreement”) is made and entered as of the 13th day of March, 2017 (“Effective Date”) by and between Dyadic International, Inc. (the “Company”), and Novaro Ltd – acting as the Consulting Company Provider (the “Provider”). The Company and Provider are each sometimes individually referred to as a “Party” and collectively, as the “Parties.” Capitalized terms used herein shall have the meaning provided in this Agreement including, but not limited to, as set forth in Section 5.8 hereof.
PHARMA LICENSE AGREEMENTPharma License Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Delaware
This PHARMA LICENSE AGREEMENT (the “Agreement”) is made as of December 31, 2015, and effective as of the Effective Date (as that term is defined below) by and between Danisco US, Inc., a Delaware corporation having a place of business at Building 356, DuPont Experimental Station, Wilmington, Delaware (“Danisco”) and Dyadic International, Inc., a Delaware corporation having its principal office at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida (“Dyadic”). Danisco and Dyadic are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.” As used in this Agreement, capitalized terms shall have the meanings indicated in Article 1 of this Agreement or as specified elsewhere in the Agreement. Other capitalized terms used but not otherwise defined herein shall have the meanings assigned to them in the Asset Purchase Agreement.
SERVICE FRAMEWORK AGREEMENTService Framework Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
This SERVICE FRAMEWORK AGREEMENT (this "Agreement"), signed as of June 30, 2017, is entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation with headquarters located at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094 USA and U.S. tax identification number 45-04867472 ("Dyadic"), and BIOTECHNOLOGY DEVELOPMENTS FOR INDUSTRY IN PHARMACEUTICALS, S.L.U., a company incorporated under the laws of Spain having its registered office at Louist Proust 13, 4 7151 Boecillo (Valladolid), Spain, and identification code -CIF number- B-86206695 ("BDI Pharmaceuticals"). Dyadic and BDI Pharmaceuticals are sometimes collectively referred to as the "Parties" and individually as a "Party." Certain capitalized terms used herein have the meanings assigned them in Article 1 hereof.
Feasibility Study AgreementDyadic International Inc • January 14th, 2019 • Industrial organic chemicals
Sanofi-Aventis Deutschland GmbH, a German corporation with its principal place of business at lndustriepark Höchst, 65926 Frankfurt am Main, Germany,
